From the publishers of JADPRO

HR+ HER2- Breast Cancer Resource Center

Advertisement

Electronic health record-based nudge intervention and axillary surgery in older women with breast cancer: A nonrandomized controlled trial

Last Updated: Thursday, September 19, 2024

Although Choosing Wisely recommendations advocate against the use of sentinel lymph node biopsy (SLNB) use in older women with early-stage, clinically node-negative, and HR+ HER2- breast cancer, it is a practice that is still widely used. To combat this overuse, investigators used an electronic health record–based nudge intervention that targeted surgeons in their first outpatient visit with patients in this population. During the nudge intervention period, unadjusted rates of SLNB decreased by 23.1 percentage points compared with rates during the control period. The investigators concluded that the nudge intervention was easily implementable and could help decrease low-value care both in this and other settings.  

JAMA Surgery
Advertisement
News & Literature Highlights

Cancers

HER2-low and HER2-ultralow metastatic breast cancer and trastuzumab deruxtecan: Common clinical questions and answers

Biomedicines

Cryotherapy as a surgical de-escalation strategy in breast cancer: Techniques, complications, and oncological outcomes

eLife

Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer

Annals of Oncology

Datopotamab deruxtecan versus chemotherapy in previously treated inoperable/metastatic hormone-receptor-positive HER2-negative breast cancer: Final overall survival analysis of the phase 3 TROPION-Breast01 study

Anti-Cancer Research

Radiological complete response as a prognostic marker in HR-positive metastatic breast cancer treated with CDK4/6 inhibitors: Implications for treatment de-escalation

Anti-Cancer Drugs

Efficacy and safety of fulvestrant combined with abemaciclib in patients with hormone receptor-positive advanced breast cancer

The Breast

How should we manage abemaciclib in the peri-operative period during secondary breast reconstruction: Balancing oncologic benefit and surgical safety

Breast Cancer Research and Treatment

Prognosis and endocrine therapy efficacy in early breast cancer with estrogen receptor low expression

JAMA

Risk-based vs annual breast cancer screening: The WISDOM randomized clinical trial

Cancer Treatment Reviews

Mechanisms and biomarkers for musculoskeletal signs and symptoms in patients treated with aromatase inhibitors: A comprehensive systematic review

Advertisement
Advertisement